114
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimen

, , , , , , & show all
Pages 673-681 | Published online: 24 Dec 2022

References

  • AgarwalSTangSSKRosenbergNDoes synchronizing initiation of therapy affect adherence to concomitant use of antihypertensive and lipid-lowering therapy?Am J Ther2008In press
  • ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research GroupMajor outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA200228829819712479763
  • BaigentCKeechAKearneyPMEfficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statinsLancet200536612677816214597
  • BangaloreSKamalakkannanGParkarSFixed-dose combinations improve medication compliance: a meta-analysisAm J Med2007120713917679131
  • BennerJSGlynnRJMogunHLong-term persistence in use of statin therapy in elderly patientsJAMA20022884556112132975
  • BlackburnDFDobsonRTBlackburnJLAdherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort studyCan J Cardiol200521485815917876
  • BlankRLaSalleJReevesRSingle-pill therapy in the treatment of concomitant hypertension and dyslipidemia (the amlodipine/atorvastatin Gemini study)J Clin Hypertens (Greenwich)200572647315886529
  • BramleyTJGerbinoPPNightengaleBSRelationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizationsJ Manag Care Pharm2006122394516623608
  • BurnierMMedication adherence and persistence as the cornerstone of effective antihypertensive therapyAm J Hypertens2006191190617070434
  • ChapmanRHBennerJSPetrillaAAPredictors of adherence with antihypertensive and lipid-lowering therapyArch Intern Med200516511475215911728
  • D’AgostinoRBJrPropensity score methods for bias reduction in the comparison of a treatment to a non-randomized control groupStat Med1998172265819802183
  • D’AgostinoRBJrD’AgostinoRBSrEstimating treatment effects using observational dataJAMA2007297314617227985
  • D’AgostinoRBKwanHMeasuring effectiveness. What to expect without a randomized control groupMed Care199533AS951057723466
  • DeziiCMA retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertensionManag Care200092611729417
  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsExecutive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)JAMA200128524869711368702
  • First DataBank IncNDDF File2006San Bruno, CAThe Hearst Corporation
  • GerbinoPPShoheiberOAdherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agentsAm J Health Syst Pharm20076412798317563050
  • HalpernMTKhanZMSchmierJKRecommendations for evaluating compliance and persistence with hypertension therapy using retrospective dataHypertension20064710394816651464
  • Heart Protection Study Collaborative GroupMRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trialLancet200236072212114036
  • HiranoKImbensGWEstimations of causal effects using propensity score weighting: an application to data on right heart catheterizationHealth Serv Outcome Res Meth2001225978
  • HoPMRumsfeldJSMasoudiFAEffect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitusArch Intern Med200616618364117000939
  • KulkarniSPAlexanderKPLytleBLong-term adherence with cardiovascular drug regimensAm Heart J20061511859116368315
  • LarsenJAndersenMKragstrupJHigh persistence of statin use in a Danish population: compliance study 1993–1998Br J Clin Pharmacol200253375811966668
  • LopezVAFranklinSSTangSCoronary heart disease events preventable by control of blood pressure and lipids in US adults with hypertensionJ Clin Hypertens (Greenwich)200794364317541329
  • LuncefordJKDavidianMStratification and weighting via the propensity score in estimation of causal treatment effects: a comparative studyStat Med20042329376015351954
  • McCombsJSNicholMBNewmanCMThe costs of interrupting antihypertensive drug therapy in a Medicaid populationMed Care199432214268145599
  • PatelBVRemigio-BakerRAMehtaDEffects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United StatesJ Clin Hypertens (Greenwich)2007969270017786070
  • PietteJDHeislerMWagnerTHCost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at riskAm J Public Health2004941782715451750
  • SchneeweissSSeegerJDLandonJAprotinin during coronary-artery bypass grafting and risk of deathN Engl J Med20083587718318287600
  • SeverPSDahlöfBPoulterNRPrevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialLancet200336111495812686036
  • SokolMCMcGuiganKAVerbruggeRRImpact of medication adherence on hospitalization risk and healthcare costMed Care2005435213015908846
  • SoumeraiSBPierre-JacquesMZhangFCost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefitArch Intern Med200616618293517000938
  • StaessenJAWangJGThijsLCardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003J Hypertens20032110557612777939
  • SteinerJFProchazkaAVThe assessment of refill compliance using pharmacy records: methods, validity, and applicationsJ Clin Epidemiol199750105169048695
  • SullivanPWNairKVPatelBVThe effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapyAm J Manag Care2005113748215974556
  • ThiebaudPPatelBVNicholMBImpact of rofecoxib withdrawal on cyclooxygenase-2 utilization among patients with and without cardiovascular riskValue Health20069361817076866
  • ThiebaudPPatelBVNicholMBThe demand for statin: the effect of copay on utilization and complianceHealth Econ200817839717585395
  • ThiebaudPPatelBVNicholMBThe effect of switching on compliance and persistence: the case of statin treatmentAm J Manag Care200511670416268750
  • VanderpoelDRHusseinMAWatson-HeidariTAdherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysisClin Ther20042620667515823770
  • WeiLWangJThompsonPAdherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up studyHeart2002882293312181210
  • WongNDLopezVTangSPrevalence, treatment, and control of combined hypertension and hypercholesterolemia in the United StatesAm J Cardiol200698204816828593